Rizzo A - Search Results

1

Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trials.

Longo V, Rizzo A, Catino A, Montrone M, Galetta D. Longo V, et al. Among authors: rizzo a. Thorac Cancer. 2023 Apr;14(11):1029-1035. doi: 10.1111/1759-7714.14842. Epub 2023 Mar 3. Thorac Cancer. 2023. PMID: 36869579 Free PMC article.

2

Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis.

Rizzo A, Mollica V, Santoni M, Palmiotti G, Massari F. Rizzo A, et al. J Clin Med. 2022 Feb 17;11(4):1038. doi: 10.3390/jcm11041038. J Clin Med. 2022. PMID: 35207311 Free PMC article. Review.

3

Fluoropyrimidine-based doublet chemotherapy as second-line treatment for advanced biliary tract cancer: a meta-analysis of ABC-06 and NIFTY.

Rizzo A, Cusmai A, Giovannelli F, Acquafredda S, Rinaldi L, Misino A, Palmiotti G. Rizzo A, et al. Expert Rev Gastroenterol Hepatol. 2022 Mar;16(3):273-278. doi: 10.1080/17474124.2022.2047651. Epub 2022 Mar 2. Expert Rev Gastroenterol Hepatol. 2022. PMID: 35220866

4

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.

Rizzo A, Cusmai A, Giovannelli F, Acquafredda S, Rinaldi L, Misino A, Montagna ES, Ungaro V, Lorusso M, Palmiotti G. Rizzo A, et al. Cancers (Basel). 2022 Mar 9;14(6):1404. doi: 10.3390/cancers14061404. Cancers (Basel). 2022. PMID: 35326555 Free PMC article. Review.

5

Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?

Rizzo A, Cusmai A, Gadaleta-Caldarola G, Palmiotti G. Rizzo A, et al. Expert Rev Gastroenterol Hepatol. 2022 Apr;16(4):333-339. doi: 10.1080/17474124.2022.2064273. Epub 2022 Apr 10. Expert Rev Gastroenterol Hepatol. 2022. PMID: 35403533

6

Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-Analysis.

Righini M, Mollica V, Rizzo A, La Manna G, Massari F. Righini M, et al. Among authors: rizzo a. J Clin Med. 2022 Jul 27;11(15):4373. doi: 10.3390/jcm11154373. J Clin Med. 2022. PMID: 35955989 Free PMC article. Review.

7

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer.

Rizzo A. Rizzo A. Thorac Cancer. 2022 Nov;13(21):3098. doi: 10.1111/1759-7714.14619. Epub 2022 Aug 21. Thorac Cancer. 2022. PMID: 35989551 Free PMC article. No abstract available.

8

Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.

Viscardi G, Tralongo AC, Massari F, Lambertini M, Mollica V, Rizzo A, Comito F, Di Liello R, Alfieri S, Imbimbo M, Della Corte CM, Morgillo F, Simeon V, Lo Russo G, Proto C, Prelaj A, De Toma A, Galli G, Signorelli D, Ciardiello F, Remon J, Chaput N, Besse B, de Braud F, Garassino MC, Torri V, Cinquini M, Ferrara R. Viscardi G, et al. Among authors: rizzo a. Eur J Cancer. 2022 Dec;177:175-185. doi: 10.1016/j.ejca.2022.09.031. Epub 2022 Oct 5. Eur J Cancer. 2022. PMID: 36368251 Review.

9

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Guven DC, Sahin TK, Erul E, Rizzo A, Ricci AD, Aksoy S, Yalcin S. Guven DC, et al. Among authors: rizzo a. Front Mol Biosci. 2022 Dec 2;9:1039121. doi: 10.3389/fmolb.2022.1039121. eCollection 2022. Front Mol Biosci. 2022. PMID: 36533070 Free PMC article.

10

Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.

Santoni M, Rizzo A, Kucharz J, Mollica V, Rosellini M, Marchetti A, Tassinari E, Monteiro FSM, Soares A, Molina-Cerrillo J, Grande E, Battelli N, Massari F. Santoni M, et al. Among authors: rizzo a. Cancer Immunol Immunother. 2023 Jun;72(6):1365-1379. doi: 10.1007/s00262-022-03349-4. Epub 2023 Jan 12. Cancer Immunol Immunother. 2023. PMID: 36633661 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,908 results

Search Page